Eric Venker, Chief Operating Officer at Roivant Sciences (NASDAQ:ROIV), reported a large exercise of company stock options on September 7, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Venker, Chief Operating Officer at Roivant Sciences, a company in the Health Care sector, just exercised stock options worth 93,964 shares of ROIV stock with an exercise price of $3.85.
Roivant Sciences shares are trading down 0.85% at $11.69 at the time of this writing on Thursday morning. Since the current price is $11.69, this makes Venker's 93,964 shares worth $1,098,439.